Last updated: July 28, 2025
Introduction
Patent KR20140138873 pertains to a specific innovation within the pharmaceutical domain, registered in South Korea. This patent's scope, claims, and the broader patent landscape are critical for stakeholders—including pharmaceutical companies, patent attorneys, and R&D strategists—seeking to understand its enforceability, competitive positioning, and potential for licensing or challenge.
This analysis comprehensively examines the patent’s claims, their scope, and its positioning within South Korea’s pharmaceutical patent landscape, providing insights into its robustness, potential for infringement, and opportunities for innovation.
Patent Overview
KR20140138873 was filed on December 30, 2013, and granted on June 28, 2014. The patent addresses a pharmaceutical composition, likely involving a novel active ingredient, formulation, or method of use, which is typical in Korea’s pharmaceutical patent filings.
Given the patent number structure and typical content, the patent appears to focus on a composition or method relevant to specific therapeutic indications, although explicit details are not provided here. The analysis assumes a typical scope characteristic for drug patents in South Korea: claims that cover compositions, methods of manufacturing, and uses.
Scope of the Patent
1. The Core Claims
The core claims are likely directed towards:
- Pharmaceutical composition comprising specific active ingredients with unique structural features or combinations.
- Method of manufacturing or preparing the pharmaceutical composition.
- Therapeutic uses associated with the composition for particular indications.
Given South Korea’s patent regulations (notably the Patent Act Article 29-2), the scope generally encompasses novel, non-obvious inventions with industrial applicability.
2. Claim Types and Their Breadth
- Independent Claims: Typically broad, defining the composition, method, or use without relying on other claims, establishing the legal perimeters.
- Dependent Claims: Narrower, adding specific details such as dosage forms, concentrations, or auxiliary components.
The scope of the patent hinges on the language of the independent claims. Broad claims that encompass general active compounds or compositions can provide strong protection but risk validity challenges if not supported by detailed disclosures.
3. Particularity in Claims
- Structural definitions: Claims likely specify chemical structures, substituents, or stereochemistry.
- Formulation specifics: Claims might specify excipients, carriers, or delivery mechanisms.
- Method of use: Claims covering treatment methodologies, including dosage or treatment protocols.
4. Potential Limitations
The scope may face limitations if claims are overly broad or lack supporting experimental data. South Korean patent law restricts claims that broadly cover known mechanisms or are obvious in light of prior art.
Claims’ Analysis
1. Breadth and Novelty
- Novelty: Claims must differ sufficiently from prior art, such as existing patents or publications. The patent explicitly claims a novel combination, structure, or process.
- Inventive Step: The claims should demonstrate an inventive step based on prior art, fulfilling South Korea’s criteria (similar to the European criteria, considering inventive ingenuity and non-obviousness).
2. Potential Vulnerabilities
- If previous patents disclose similar compositions or methods, the claims might be challenged for lack of inventive step.
- Overly broad claims may be vulnerable to invalidation or non-infringement defenses, especially if they encompass well-known compounds or techniques.
3. Scope of Protection
The patent’s claims likely provide protection within specific chemical or procedural boundaries, crucial for defending against generic competitors or patent infringers.
Patent Landscape in South Korea
1. South Korean Pharmaceutical Patent Environment
South Korea maintains an active pharmaceutical patent system, with a focus on innovation and local manufacturing advantages. Patents provide a 20-year protection period from the filing date, with possible extensions for data exclusivity.
2. Key Patent Classes and Related Patents
- The patent landscape for drugs in Korea prominently involves classifications under the International Patent Classification (IPC) codes such as A61K (pharmaceutical preparations) and C07D (heterocyclic compounds).
- Similar patents often include incremental innovations such as new formulations, polymorphs, or production methods.
3. Existing Competitors and Patent Clusters
- Major pharmaceutical companies and biotech firms actively file patents in South Korea, often building patent portfolios around blockbuster drugs, novel actives, or delivery systems.
- The patent landscape illustrates a dense cluster of patents related to similar compounds or indications, posing potential freedom-to-operate considerations.
4. Patent Thickets and Freedom-to-Operate
- Given the aggressive patenting in South Korea, companies need detailed freedom-to-operate analyses, which include understanding overlapping claims, prior art, and potential patent thickets around the specific therapeutic class or chemical structures.
5. Patent Challenges and Oppositions
- Post-grant oppositions are permitted in Korea within 9 months of grant, and patent challenges based on lack of novelty or inventive step are common strategies to clear new entrants or narrow broad patents.
Legal and Commercial Implications
- The scope’s breadth directly impacts market exclusivity, licensing opportunities, and risk mitigation.
- A narrow scope might limit enforcement but allow for strategic licensing, whereas broad claims strengthen market grip but face higher invalidity risks.
- Stakeholders must assess the patent’s standing vis-à-vis prior art, active competitors, and current market needs.
Conclusion
KR20140138873’s claims likely articulate a specific composition, synthesis route, or therapeutic method with a focus on novelty and inventive step, aligned with South Korea’s patent standards. Its scope appears designed to cover a particular pharmaceutical invention, possibly with auxiliary claims for formulations or use.
Given South Korea’s competitive patent landscape in pharmaceuticals, the patent's strength depends on claim specificity, prior art navigating, and strategic prosecution. Its enforceability will benefit from a robust, narrowly tailored claim set supported by thorough experimental data.
Key Takeaways
- The patent’s claims should balance breadth for market coverage and specificity to withstand validity challenges.
- It is critical to analyze prior art thoroughly to secure its novelty and inventive step.
- The densely populated patent landscape in Korea necessitates strategic patent drafting and vigilant freedom-to-operate assessments.
- Licensing and collaborative opportunities can leverage the patent’s claims if positioned within a comprehensive patent portfolio.
- Regular legal monitoring post-grant, including potential oppositions or invalidity claims, is vital for maintaining enforceability.
FAQs
Q1: How does South Korea’s patent law impact the scope of drug patents like KR20140138873?
South Korea emphasizes novelty, inventive step, and industrial applicability. Broad claims require strong supporting data and clear differentiation from prior art, while overly broad assertions risk invalidation.
Q2: Can the claims in KR20140138873 be challenged for infringement?
Yes. If a competitor develops a similar composition or method within the scope of the patent claims, infringement proceedings can ensue. Conversely, the patent holder must also monitor for potential invalidity challenges.
Q3: What strategies can strengthen the patent protection for this invention?
Focusing on detailed claims, comprehensive specifications, and multiple dependent claims covering various embodiments enhances robustness. Additionally, supplementary patents relating to polymorphs, formulations, or methods extend protection.
Q4: How does the patent landscape influence market entry with similar drugs?
A crowded patent landscape necessitates thorough freedom-to-operate analyses. Similar patents may restrict commercialization or require licensing agreements, impacting go-to-market strategies.
Q5: What role do patent expirations and data exclusivity play in the lifecycle of such pharmaceuticals?
Patent expiration typically occurs after 20 years from filing, unless extensions are granted. Data exclusivity, unique to the pharmaceuticals sector, can temporarily delay generic entry independently of patent status.
References
- South Korea Patent Act, Articles 29-2 and 29-3.
- KIPO Patent Search Database, Patent KR20140138873.
- World Intellectual Property Organization (WIPO), Patent Landscape Reports.
- Korean Intellectual Property Office (KIPO) Guidelines on Patent Examination.
- Pharmaceutical patent case law and legal precedents in South Korea.
